Cargando…

Clearance of BK Virus Nephropathy by Combination Antiviral Therapy With Intravenous Immunoglobulin

BACKGROUND: Reactivation of BK polyoma virus causes a destructive virus allograft nephropathy (BKVAN) with graft loss in 46%. Treatment options are limited to reduced immunosuppression and largely ineffective antiviral agents. Some studies suggest benefit from intravenous immunoglobulin (IVIG). METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kable, Kathy, Davies, Carmen D., O'connell, Philip J., Chapman, Jeremy R., Nankivell, Brian John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Kidney Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381735/ https://www.ncbi.nlm.nih.gov/pubmed/28405598 http://dx.doi.org/10.1097/TXD.0000000000000641

Ejemplares similares

Polyomavirus BK Nephropathy-Associated Transcriptomic Signatures: A Critical Reevaluation
por: Pan, Ling, et al.
Publicado: (2018)

Donor-derived Cell-free DNA and the Prediction of BK Virus-associated Nephropathy
por: Kant, Sam, et al.
Publicado: (2020)

BK Viremia Exacerbation With Adalimumab Coadministration
por: Lum, Erik L., et al.
Publicado: (2020)

Successful Desensitization of T cell Flow Cytometry Crossmatch Positive Renal Transplant Recipients Using Plasmapheresis and Super High-Dose Intravenous Immunoglobulin
por: Kakuta, Yoichi, et al.
Publicado: (2017)

Prediction of Early BK Virus Infection in Kidney Transplant Recipients by the Number of Cells With Intranuclear Inclusion Bodies (Decoy Cells)
por: Yamada, Yoshiteru, et al.
Publicado: (2018)

Delayed Graft Function Among Kidney Transplant Recipients Is Associated With an Increased Risk of Urinary Tract Infection and BK Viremia
por: Alshaikh, Eman A., et al.
Publicado: (2023)

Predictive Models for Recurrent Membranous Nephropathy After Kidney Transplantation
por: Chung, Edmund Y. M., et al.
Publicado: (2022)

Octreotide Delaying the Progression of Recurrent IgA Nephropathy After Kidney Transplantation
por: Sharma, Akhil, et al.
Publicado: (2019)

Direct-acting Antivirals for the Treatment of Kidney Transplant Patients With Chronic Hepatitis C Virus Infection in Spain: A Long-term Prospective Observational Study
por: González-Corvillo, Carmen, et al.
Publicado: (2019)

Assessment of a Dedicated Transplant Low Clearance Clinic and Patient Outcomes on Dialysis After Renal Allograft Loss at 2 UK Transplant Centers
por: Evans, Rhys D.R., et al.
Publicado: (2018)

Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial
por: Busque, Stephan, et al.
Publicado: (2018)

The Association Between Broad Antigen HLA Mismatches, Eplet HLA Mismatches and Acute Rejection After Kidney Transplantation
por: Do Nguyen, Hung Thanh, et al.
Publicado: (2016)

Baseline Characteristics and Representativeness of Participants in the BEST-Fluids Trial: A Randomized Trial of Balanced Crystalloid Solution Versus Saline in Deceased Donor Kidney Transplantation
por: Collins, Michael G., et al.
Publicado: (2022)

Antithrombin Perfluorocarbon Nanoparticles Improve Renal Allograft Function in a Murine Deceased Criteria Donor Model
por: Vemuri, Chandu, et al.
Publicado: (2018)

Perspectives on Quality of Care in Kidney Transplantation: A Semistructured Interview Study
por: Brett, Kendra E., et al.
Publicado: (2018)

Successful Implementation of an Increased Viral Risk Donor Waiting List for Preconsented Kidney Transplant Candidates in Victoria, Australia
por: Lee, Darren, et al.
Publicado: (2021)

Nuclear Factor of Activated T Cell-regulated Cytokine Gene Expression for Adjustment of Tacrolimus in Kidney Transplant Recipients: A Randomized Controlled Pilot Trial
por: Webber, Allison B., et al.
Publicado: (2018)

MHC Class I Masking to Prevent AMR in a Porcine Kidney Transplantation Model in Alloimmunized Recipients
por: Kervella, Delphine, et al.
Publicado: (2023)

Prolonged Delayed Renal Graft Function Secondary to Venous Hypertension
por: Mishra, Suraj, et al.
Publicado: (2017)

Complement Markers in Blood and Urine: No Diagnostic Value in Late Silent Antibody-Mediated Rejection
por: Mező, Blanka, et al.
Publicado: (2019)

Trends in Living Donation by Race and Ethnicity Among Children With End-stage Renal Disease in the United States, 1995–2015
por: Amaral, Sandra, et al.
Publicado: (2020)

Anti-interleukin-6 Antibody Clazakizumab in Antibody-mediated Kidney Transplant Rejection: Effect on Donor-derived Cell-free DNA and C-X-C Motif Chemokine Ligand 10
por: Mayer, Katharina A., et al.
Publicado: (2022)

HLA Matching Trumps Donor Age: Donor-Recipient Pairing Characteristics That Impact Long-Term Success in Living Donor Kidney Transplantation in the Era of Paired Kidney Exchange
por: Milner, John, et al.
Publicado: (2016)

Transplantation Amid a Pandemic: The Fall and Rise of Kidney Transplantation in the United States
por: Bisen, Shivani S., et al.
Publicado: (2022)

Using Laser Speckle Contrast Imaging to Quantify Perfusion Quality in Kidney and Pancreas Grafts on Vascular Reperfusion: A Proof-of-Principle Study
por: Gopal, Jeevan Prakash, et al.
Publicado: (2023)

The Spanish Version of the Fear of Kidney Failure Questionnaire: Validity, Reliability, and Characterization of Living Donors With the Highest Fear of Kidney Failure
por: Torres, Xavier, et al.
Publicado: (2021)

New-Onset Gout as an Independent Risk Factor for Returning to Dialysis After Kidney Transplantation
por: Li, Justin W., et al.
Publicado: (2020)

High-activity Classical and Alternative Complement Pathway Genotypes—Association With Donor-specific Antibody-triggered Injury and Renal Allograft Survival
por: Mező, Blanka, et al.
Publicado: (2020)

A Randomized Controlled Trial of a Mobile Medical App for Kidney Transplant Recipients: Effect on Use of Sun Protection
por: Robinson, June K., et al.
Publicado: (2015)

The World's Youngest Cadaveric Kidney Transplant: Medical, Surgical and Ethical Issues
por: Daar, Abdallah S., et al.
Publicado: (2016)

Increased Telomere Attrition After Renal Transplantation—Impact of Antimetabolite Therapy
por: Luttropp, Karin, et al.
Publicado: (2016)

Successful Kidney Transplantation After Stepwise Desensitization Using Rituximab and Bortezomib in a Highly HLA-Sensitized and ABO Incompatible High Titer Patient
por: Inui, Masashi, et al.
Publicado: (2016)

Rituximab in Combination With Bortezomib, Plasmapheresis, and High-Dose IVIG to Treat Antibody-Mediated Renal Allograft Rejection
por: Waiser, Johannes, et al.
Publicado: (2016)

Classification of Kidney Transplant Recipients Using a Combination of Estimated GFR and Albuminuria Reflects Risk
por: White, Christine A., et al.
Publicado: (2016)

Assessment of 4 Cases of Kidney Transplantation from Hepatitis C Virus Antibody-Positive and RNA-Negative Donors to Antibody-Negative Recipients
por: Unagami, Kohei, et al.
Publicado: (2016)

Early Kidney Allograft Dysfunction (Threatened Allograft): Comparative Effectiveness of Continuing Versus Discontinuation of Tacrolimus and Use of Sirolimus to Prevent Graft Failure: A Retrospective Patient-Centered Outcome Study
por: Wali, Ravinder K., et al.
Publicado: (2016)

Human Cytomegalovirus Infection Enhances NK Cell Activity In Vitro
por: Tschan-Plessl, Astrid, et al.
Publicado: (2016)

A Prospective Study of Renal Transplant Recipients: A Fall in Insulin Secretion Underpins Dysglycemia After Renal Transplantation
por: Langsford, David, et al.
Publicado: (2016)

Resolution of Calciphylaxis After Urgent Kidney Transplantation in 3 Patients With End-Stage Kidney Failure
por: Nordheim, Espen, et al.
Publicado: (2016)

Graft Growth and Podocyte Dedifferentiation in Donor-Recipient Size Mismatch Kidney Transplants
por: Müller-Deile, Janina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p1ib38lrjhvfrnvao6sjhrc475